Wegovy Cash Price: What You Pay Without Insurance

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This explainer lives in the PlexusDx Education Hub. Browse every Peptides & GLP-1 guide for the wider library.

"Wegovy cash price" is a question people ask when they want to know the counter cost without an insurance cushion. The honest answer starts with a published list price and then bends around a handful of variables. This page walks through the sticker figure, what changes it at the pharmacy, and the compounded pathway that sits alongside the brand, all as of April 2026. The Education Hub holds related guides.

The published list price

Wegovy's list price is roughly $1,349 per month at U.S. list as of April 2026, per Novo Nordisk's published pricing. That figure is the starting line, not the finish; it precedes any insurance, rebate, manufacturer savings card, or pharmacy negotiation. For a true cash payer with none of those levers, the list price is close to what appears at the register, which is why the number lands so hard in cash-price searches.

What moves the number at the counter

Several variables sit between the list price and the amount you actually pay: insurance coverage, the FDA-approved indication written on the prescription, eligibility for a manufacturer savings card, and the specific pharmacy's pricing. Remove insurance from that list and most of the discounting levers go with it, which is exactly why cash prices run so much higher than what an insured, covered patient reports paying.

Savings tools a cash payer can still reach

Even without insurance, some tools remain. Novo Nordisk publishes a manufacturer savings card, though eligibility generally requires commercial insurance and excludes government plans like Medicare, Medicaid, and TRICARE. Independent discount platforms such as GoodRx and SingleCare publish coupon prices that vary by pharmacy. These change frequently, so verifying the current terms at the time of fill is worth the few minutes it takes.

The compounded pathway alongside the brand

During the FDA-declared shortages of semaglutide and tirzepatide, licensed 503A compounding pharmacies legally produced compounded formulations of these molecules. The FDA resolved the semaglutide shortage in late 2024 and the tirzepatide shortage in early 2025, which narrowed the window without eliminating all legitimate compounding activity. Compounded products are not identical to the FDA-approved brand and are priced separately through their own pathway.

Scenarios in plain terms

With commercial insurance that covers the indication plus an applied savings card, eligible patients may pay as little as $25 per month, subject to plan terms and caps. With commercial insurance that does not cover the indication, cash cost lands closer to list price minus whatever coupon applies. With no insurance at all, cash cost approaches list price, and the compounded option through PlexusDx carries its own published pricing on each product page.

Genetics before any spend

Before committing dollars to any route, it helps to understand the biology you bring. The PlexusDx Precision Peptide Genetic Test reads 14 pathways, 49 peptides, 150+ genetic insights, including variants in FTO, and MC4R that shape baseline appetite and energy balance. This is pathway education from 503A-aligned testing. It does not predict your response to any medication and is not pharmacogenomic; it is upstream context, not a purchase guarantee.

What PlexusDx offers

PlexusDx provides semaglutide and tirzepatide through its Weight Management Protocols, offered as Semaglutide Injection, Semaglutide Oral, and Tirzepatide Injection, each with pricing published on its product page. It does not sell or recommend other GLP-1 category peptides such as dulaglutide, liraglutide, retatrutide, or cagrilintide.

Reading a quoted price accurately

When you see a Wegovy price online, the first question is which situation it assumes. A figure near $25 reflects insurance plus a savings card; a figure near list price reflects true cash pay; a compounded figure comes from an entirely separate pathway. Numbers pulled out of that context mislead more than they help. Matching any quote to the scenario behind it is the single most useful habit for a cash-focused shopper.

Frequently Asked Questions

What is the cash price of Wegovy?

Wegovy's list price is about $1,349 per month at U.S. list as of April 2026, per Novo Nordisk's published pricing. For a true cash payer without insurance or a savings card, that list figure is close to the register price. Coupons from independent platforms may trim it somewhat, but cash cost sits far above what covered patients report.

Can I lower the cash price without insurance?

Some levers remain. Independent discount platforms like GoodRx and SingleCare publish coupon prices that vary by pharmacy, and manufacturer savings cards may help, though those typically require commercial insurance. Compounded semaglutide through a licensed 503A pharmacy is priced separately. Verify current terms at the time of fill, since they change often.

Why is the cash price so high?

Wegovy is a branded, patent-protected medication, and its list price precedes the insurance, rebate, and savings mechanisms that normally reduce what patients pay. Strip those away, as a cash payer does, and little stands between you and the list figure. That structural gap is what makes cash-price searches so striking.

Is a compounded version cheaper?

Compounded semaglutide prepared by licensed 503A pharmacies is priced through its own pathway, separate from the brand, and is not identical to Wegovy or a generic of it. Whether it is appropriate is a clinical decision. PlexusDx publishes per-protocol pricing on each product page for its semaglutide and tirzepatide options.

This explainer lives in the PlexusDx Education Hub. Browse every Peptides & GLP-1 guide for the wider library.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.